Bangkok Dusit Medical Services (BDMS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Sep, 2026Executive summary
Operating income for 4Q25 reached THB 29,022 million, up 4% year-over-year, with hospital revenue at THB 27,421 million, also up 4% YoY.
For 2025, operating income was THB 113,206 million (+4% YoY), and hospital revenue was THB 107,514 million (+4% YoY).
International patient revenue grew 5% YoY in 2025, with notable growth from Myanmar (+31%), Qatar (+36%), and the USA (+19%).
Excluding Cambodia, international patient revenue increased 11% YoY in 2025.
Financial highlights
Adjusted EBITDA margin for 2025 was 24.1%, and adjusted NPAT margin was 14.5%.
Adjusted EBITDA for 2025 was THB 27,426 million (+4% YoY), and adjusted NPAT was THB 16,187 million (+2% YoY).
Special items in 2025 totaled THB 416 million (before tax) due to flooding in Hat Yai and accounting adjustments.
Center of Excellence contributed 54% of hospital EBITDA in 2025.
Outlook and guidance
Strategic direction for 2026 focuses on improving outcomes, enhancing efficiency, and delivering integrated care.
Expansion projects include new hospitals and facilities, targeting ~9,600 beds by 2027.
Emphasis on smart healthcare, AI adoption, and digital transformation to drive efficiency and care quality.
Latest events from Bangkok Dusit Medical Services
- Operating income and revenue rose slightly, but net profit fell on higher depreciation and expenses.BDMS
Q2 2026 - Southeast Asia's largest health-tech provider leads in diagnostics, genomics, and regional expansion.BDMS
Corporate presentation - Flat operating income and hospital revenue, with a THB 1 per share dividend approved.BDMS
Q1 2026 - Net profit rose to ฿12.16 billion on higher revenue, international growth, and network expansion.BDMS
Q3 2025 - Revenue and profit grew 5–6% YoY, led by international patients and strong hospital operations.BDMS
Q2 2025 - 9M24 net profit rose 12% to ฿11.65 billion on revenue of ฿81.6 billion, driven by patient growth.BDMS
Q3 2024 - Net profit rose 14% in H1 2024, driven by hospital growth and international patient revenue.BDMS
Q2 2024 - Net profit rose over 6% YoY, supported by international and upcountry hospital growth.BDMS
Q1 2025 - 2024 saw double-digit net profit growth, strong international patient demand, and major expansion projects.BDMS
Q4 2024